Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Robyn

Showing results (101-110 of 142) with videos related to

Pageof 15
Sort By:
Revue Francaise De Gynecologie Et D'Obstetrique|December 1, 1978
[Estrogenic stimulation of the follicular phase of the human menstrual cycle: neuro endocrinian investigation (author's transl)]J P Gautray, A Jolivet, C Robyn, et al.
Annales D'Endocrinologie|January 1, 1977
[Neuroendocrine investigation of the follicular phase: spontaneous and after estrogen stimulation (author's transl)]J P Gautray, A Jolivet, C Robyn, et al.
American Journal of Obstetrics and Gynecology|April 15, 1974
Serum progesterone in nonpregnant women. I. Comparative study of serum progesterone concentration and urinary pregnanediol excretionH Askalani, M Smuk, J Sugar, et al.
Maturitas|November 1, 1993
Decrease of bone mineral density during estrogen substitution therapyS Rozenberg, R Gevers, A Peretz, et al.
Nuclear Medicine Communications|March 1, 1991
Choice of parameter for expressing bone mineralizationS Rozenberg, H Ham, A Peretz, et al.
Obstetrics and Gynecology|December 1, 1976
Treatment of fibrocystic disease of the breast with a prolactin inhibitor: 2-Br-alpha-ergocryptine (CB-154)J Martin-Comin, P Pujol-Amat, V Cararach, et al.
Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles|March 19, 1973
[Simultaneous study of circadian variations of blood thyrotropin (TSH) and pituitary prolactin levels in man]M L Vanhaelst, J Golstein, E Van Cauter, et al.
Journal of Reproduction and Fertility|December 1, 1973
Proceedings: Plasma levels of LH, FSH and prolactin in women during and after insertion of an intrauterine deviceA Fortuny, P Pujol-Amat, J Calaf, et al.
Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique|January 1, 1975
[Clinical pharmacology of hormonal contraceptives]P O Hubinont, M Degueldre, P Delvoye, et al.
Gynecologic Investigation|January 1, 1971
Inhibition of DMBA-induced mammary carcinogenesis in the rat by 2-br- -ergocryptine (CB 154), an inhibitor of prolactin secretion, and by nafoxidine (U-11, 100 A), an estrogen antagonistJ C Heuson, C Waelbroeck, N Legros, et al.
Pageof 15

Showing results (101-110 of 142) with videos related to

Sort By:
Pageof 15
Revue Francaise De Gynecologie Et D'Obstetrique|December 1, 1978
[Estrogenic stimulation of the follicular phase of the human menstrual cycle: neuro endocrinian investigation (author's transl)]J P Gautray, A Jolivet, C Robyn, et al.
Annales D'Endocrinologie|January 1, 1977
[Neuroendocrine investigation of the follicular phase: spontaneous and after estrogen stimulation (author's transl)]J P Gautray, A Jolivet, C Robyn, et al.
American Journal of Obstetrics and Gynecology|April 15, 1974
Serum progesterone in nonpregnant women. I. Comparative study of serum progesterone concentration and urinary pregnanediol excretionH Askalani, M Smuk, J Sugar, et al.
Maturitas|November 1, 1993
Decrease of bone mineral density during estrogen substitution therapyS Rozenberg, R Gevers, A Peretz, et al.
Nuclear Medicine Communications|March 1, 1991
Choice of parameter for expressing bone mineralizationS Rozenberg, H Ham, A Peretz, et al.
Obstetrics and Gynecology|December 1, 1976
Treatment of fibrocystic disease of the breast with a prolactin inhibitor: 2-Br-alpha-ergocryptine (CB-154)J Martin-Comin, P Pujol-Amat, V Cararach, et al.
Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles|March 19, 1973
[Simultaneous study of circadian variations of blood thyrotropin (TSH) and pituitary prolactin levels in man]M L Vanhaelst, J Golstein, E Van Cauter, et al.
Journal of Reproduction and Fertility|December 1, 1973
Proceedings: Plasma levels of LH, FSH and prolactin in women during and after insertion of an intrauterine deviceA Fortuny, P Pujol-Amat, J Calaf, et al.
Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique|January 1, 1975
[Clinical pharmacology of hormonal contraceptives]P O Hubinont, M Degueldre, P Delvoye, et al.
Gynecologic Investigation|January 1, 1971
Inhibition of DMBA-induced mammary carcinogenesis in the rat by 2-br- -ergocryptine (CB 154), an inhibitor of prolactin secretion, and by nafoxidine (U-11, 100 A), an estrogen antagonistJ C Heuson, C Waelbroeck, N Legros, et al.
Pageof 15